Showing results (111-120 of 170) with videos related to
Sort By:
Pageof 17
Cancer Cell|June 10, 2008
DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modificationsXia Jiang, Jing Tan, Jingsong Li, et al.Cancer Research|November 5, 2002
Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cellsYao-Yu Eric Chuang, Yidong Chen, Gadisetti, et al.Oncogene|October 9, 2002
Identification of Src transformation fingerprint in human colon cancerRenae L Malek, Rosalyn B Irby, Qingbin M Guo, et al.Oncogene|February 4, 2005
Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumorsHyun Ju Kang, Suk Woo Nam, Hyunki Kim, et al.BMC Medicine|July 4, 2006
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort studyPer Hall, Alexander Ploner, Judith Bjöhle, et al.Genome Biology|September 12, 2006
Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sitesVinsensius B Vega, Chin-Yo Lin, Koon Siew Lai, et al.Breast Cancer Research : BCR|April 13, 2007
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancerChin-Yo Lin, Anders Ström, Say Li Kong, et al.BMC Infectious Diseases|September 11, 2004
A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infectionLisa F P Ng, Martin L Hibberd, Eng-Eong Ooi, et al.Science Translational Medicine|July 20, 2022
Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomasFrancesca Menghi, Kalyan Banda, Pooja Kumar, et al.Neoplasia (New York, N.Y.)|December 21, 2010
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinomaNagarajan Kannan, Jian Kang, Xiangjun Kong, et al.Pageof 17